
|Articles|February 1, 2006
Demystifying the black box warning on antidepressants: A protocol for safe prescribing in your practice
Don't let the FDA warning about suicidality discourage you from prescribing an antidepressant for the child or adolescent who needs it. These recommendations provide a guide to monitoring patients for suicidal ideation and other adverse effects.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
J&J submits sBLA for ustekinumab to treat children with ulcerative colitis 2 years and up
2
FDA approves first treatment for thymidine kinase 2 deficiency
3
Top 5 pediatric health headlines you missed in October 2025
4
FDA news in pediatrics: October 2025
5














